Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies

JAMA Cardiol. 2018 Aug 1;3(8):775-776. doi: 10.1001/jamacardio.2018.1116.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • American Heart Association
  • Arrhythmias, Cardiac / complications
  • Arrhythmias, Cardiac / therapy*
  • Brugada Syndrome / complications
  • Brugada Syndrome / therapy
  • Cardiology
  • Death, Sudden, Cardiac / etiology
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable*
  • Disease Management
  • Genetic Counseling
  • Humans
  • Long QT Syndrome / complications
  • Long QT Syndrome / therapy
  • Polymorphic Catecholaminergic Ventricular Tachycardia
  • Risk
  • Societies, Medical
  • Sympathectomy
  • Tachycardia, Ventricular / complications
  • Tachycardia, Ventricular / therapy
  • United States

Substances

  • Adrenergic beta-Antagonists

Supplementary concepts

  • Short Qt Syndrome